Invacare Corporation
IVC was delisted on the 31st of January, 2023.
10 hedge funds and large institutions have $18.4K invested in Invacare Corporation in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 54 closing their positions.
85% less funds holding
Funds holding: 66 → 10 (-56)
100% less capital invested
Capital invested by funds: $7.88M → $18.4K (-$7.86M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 54
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Charles Schwab
San Francisco,
California
|
-$1.5M |
| 2 |
First Manhattan
New York
|
-$1.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$709K |
| 4 |
Renaissance Technologies
New York
|
-$639K |
| 5 |
D.E. Shaw & Co
New York
|
-$586K |
IVC Hedge Fund Activity: Q1 2023 in Review
10 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Invacare Corporation (IVC) for Q1 2023, worth a combined $18.4K — down 100% from $7.88M a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of IVC and 0 opened new positions — a net loss of 54 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Charles Schwab, exiting entirely with an estimated $1.5M sold.
- 10 institutional investors held Invacare Corporation (IVC) as of Q1 2023, down from 66 in Q4 2022.
- Funds reported $18.4K of Invacare Corporation stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Invacare Corporation positions in Q1 2023 and 54 closed out, a net change of -54 holders.
- The largest Invacare Corporation seller in Q1 2023 was Charles Schwab, an estimated $1.5M sold.
Based on aggregated 13F filings for Q1 2023.